Navigation Links
Mark Boguski, PhD, MD, Appointed to Role of Chief Medical Officer – Precision Medicine
Date:4/18/2017

Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that Dr. Mark Boguski has been appointed to the role of Chief Medical Officer (CMO) – Precision Medicine, overseeing strategic planning and implementation of Inspirata’s precision medicine solutions.

“Dr. Boguski is widely considered a visionary leader in precision medicine, and he has extensive experience in oncology, biomedical informatics, genomics, molecular profiling,” says Inspirata CEO Satish Sanan. “In his new role as CMO, Dr. Boguski will provide thought leadership as well as strategic direction to enable healthcare organizations to implement precision medicine programs, share information and optimize operations to improve clinical outcomes.”

Prior to joining Inspirata in September 2016, Dr. Boguski was the CMO and Co-founder of Precision Medicine Network, Inc., (PMNI), where he created a molecular oncology knowledge visualization and decision support platform, called “Crosswalk Insight™: Oncology.” A pathologist by training, Dr. Boguski envisioned Crosswalk empowering the oncology care team with the necessary molecular proficiency to support the widespread adoption of precision medicine.

Since its acquisition of PMNI, Inspirata has integrated the Crosswalk platform into its existing cancer diagnostic workflow solution and its pathology consultation portal. Crosswalk is used by healthcare professionals as well as patients to easily understand and communicate critical cancer information, associated molecular pathways, targeted therapies and clinical trials. Crosswalk is easily integrated within the existing healthcare IT environment and is also available on iOS and Android mobile devices and desktop systems.

During his distinguished career, Dr. Boguski has held faculty positions at Harvard Medical School, Johns Hopkins University School of Medicine, the National Institutes of Health and National Library of Medicine, and he has had executive positions in the biotechnology and pharmaceutical industries. He founded the Genomic Medicine Initiative at Beth Israel Deaconess Medical Center in Boston, and is an elected member of the U.S. National Academy of Medicine.

About Inspirata, Inc.
Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit http://www.inspirata.com or contact info@inspirata.com.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14241046.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Former P&G VP Appointed New Industry Expert at Verixs Advisory Board
2. Gerard Morgan Appointed President of U.S. Technical Services Operation for DPS
3. Philip Goliber, PhD, Appointed Partner in Product Development and Regulatory Strategy Consulting Firm NDA Partners
4. Raymond H. Hill Appointed Chief Executive Officer and Chairman of the Board of Directors of Corrona Holdings
5. Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
6. BHIs President and CEO Rich Bendis Appointed to Maryland Life Sciences Advisory Board
7. Stephen C. Farrell Appointed to STAAR Surgical Board of Directors
8. Newly Appointed Acting CEO Outlines Immediate Plans for Novogen
9. Alexandria Real Estate Equities, Inc. CEO Joel Marcus Appointed to BIO Board
10. Michel Seidelin Appointed Chief Commercial Officer as Biomatters Prepares to Release New Offerings
11. Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... 09, 2017 , ... The Giving Tree Wellness Center announces ... needs of consumers who are incorporating medical marijuana into their wellness and health ... As operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first ... accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own ...
(Date:10/6/2017)... ... October 06, 2017 , ... On Tuesday, ... webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma (GBM). The featured ... event is free and open to the public, but registration is required. , ...
Breaking Biology Technology:
(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ... board any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to ... Delta,s biometric ... Sky Club is now integrated into the boarding process to allow ...
(Date:5/23/2017)... robotic gym for the rehabilitation and functional motor sense evaluation of lower ... . The first 30 robots will be available from June in ... The technology was developed and patented at the IIT laboratories and has ... to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
Breaking Biology News(10 mins):